Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Wednesday, November 4, 2026

Back to the front page

From X

@convequity 1 click

Convequity on X

We’ve been mega-bullish on $PLTR since late 2020. We expected it to come out on top of our SaaS Survival Scorecard. It did. Most software will sit under someone else’s AI window. Palantir is one of the few that can reasonably be that window — the place where work, decisions, and data meet. The edge is breadth plus depth. Breadth: hundreds of kinds of operational work on one substrate, not one app. Depth: it reaches down into the source data layer. A lot of the records still live in old ERP and CRM systems. Palantir doesn’t have to own those databases. It normalizes the mess, puts a shared map on top — objects, relationships, allowed actions — and that map becomes the ground truth. Think of SAP and Salesforce as the ground floor. Palantir is floor 1: where the business actually runs. That creates data gravity and speed. Once decisions live on floor 1, going around Palantir is the hard path. One thing that is not a proven Palantir product yet is refining models on the customer’s own missions — post-training and reinforcement learning on their data, with the customer keeping the weights. That is the NVIDIA Nemotron work. Until recently it was a partnership. Two weeks ago at AIPCon 11, NVIDIA showed it live in its own supply chain. That’s the first public install. Not a general customer rollout. A few months ago the stock was subdued even after strong results, on the fear that model labs would expand into Palantir’s territory. A working Nemotron collaboration takes some of that risk off the table. The risk now is different: Nemotron has to become a frontier-quality model. If it does, Palantir is the best — and probably the only — company positioned to deliver true sovereignty over enterprise intelligence. If it isn’t smart enough, post-training and RL on Palantir’s stack may still not be good enough for enterprises. Watch two windows for Nemotron progress. The nearer one is Q3 earnings commentary — Palantir usually reports that quarter in early November. Management may say more there. The other is the next AIPCon, Palantir’s customer case-study day, roughly every quarter - possibly early December. That’s where live customer proof will show up.

Investor Letters

All letters

New Ideas From The Road

Aurelion Research increased healthcare exposure and sees opportunities in banking and defense, alongside research on Alcoa, Nike, ONON and…

AA $10BNKE $60B
Aurelion Research 4 clicks

Oracle: The Party Is Almost Over

Oracle’s CDS spreads exceed 320 basis points as debt approaches $135 billion and fiscal 2027 capex targets $95 billion, amid heavy reliance…

ORCL $363B
David Desjardins 1 click

Site Centers (NYSE:SITC)

Site Centers' $3 per-share return-of-capital distribution and December delisting leave a discounted liquidation stub, with two properties…

CURB $3.6B
Real Assets, Real Value 5 clicks

Coupang: 3Q26 Business Recap

Coupang’s product-commerce growth rose 9% as data-leak effects fade, while management expects margins to return to pre-incident levels by…

CPNG $27B
Speedwell Memos 3 clicks

update on Gartner

Gartner’s growth has stalled after federal contract losses and cautious commercial spending, raising questions about its competitive…

IT $13B
scuttleblurb 1 click

Recycle Bin

Used aircraft engines can be repurposed as gas turbines, easing data center power constraints while tightening aviation supply.

EQT $33BRRC $12B
Doomberg 8 clicks
AMRZ · long

Amrize

Amrize (AMRZ) produces aggregates, cement and roofing materials across the US and Canada.

AMRZ $22B
Value Investors Club 3 clicks

AMD Earnings Review

AMD reported $13.4 billion in Q3 revenue, with Data Center sales up 97% to $8.5 billion, and guided Q4 revenue to $17 billion.

AMD $660B
Cestrian Capital Research 3 clicks

TWLO Q3 FY12/26 Earnings Review

Twilio's Q3 revenue rose 20% to $1.56 billion, but Q4 organic growth guidance fell to 11% to 12% and RPO declined 28%.

TWLO $33B
Cestrian Capital Research 3 clicks

Stevanato down 30%. Yikes.

Stevanato fell 30% after forecasting low-single-digit 2027 growth as lower Nexa syringe volumes from a GLP-1 customer offset solid Q3…

STVN $3.6B
Best Anchor Stocks 3 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 75 of 279

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.